Abstract:Historically inflammation against self was considered autoimmune which stems back to the seminal observations by Ehrlich who described serum factors, now known to be autoantibodies produced by B lineage cells that mediate "horror autotoxicus". The 20th century elucidation of B- and T-cell adaptive immune responses cemented the understanding of the key role of adaptive immune responses in mediating pathology against self. However, Mechnikov shared the Nobel Prize for the discovery of phagocytosis, the most rudimentary aspect of innate immunity. Fast forward some 100 years and an immunogenetic understanding of innate immunity led to the categorising of innate immunopathology under the umbrella term 'auto inflammation' and terminology such as "horror autoinflammaticus" to highlight the schism from the classical adaptive immune understanding of autoimmunity. These concepts lead to calls for a two-tiered classification of inflammation against self, but just as innate and adaptive immunity are functionally integrated, so is immunopathology in many settings and the concept of an autoimmune to autoinflammation continuum emerged with overlaps between both. Herein we describe several historically designated disorders of adaptive immunity where innate immunity is key, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) where the immunopathology phenotype is strongly linked to major histocompatibility complex (MHC) class II associations and responds to drugs that target T-cells. We also consider MHC-I-opathies including psoriasis and Behcet's disease(BD) that are increasingly viewed as archetype CD8 T-cell related disorders. We also briefly review the key role of barrier dysfunction in eczema and ulcerative colitis (UC) where innate tissue permeability barrier dysfunction and microbial dysbiosis contributes to prominent adaptive immune pathological mechanisms. We also highlight the emerging roles of intermediate populations of lymphocytes including gamma delta (γδ) and mucosal-associated invariant T (MAIT) cells that represent a blend of adaptive immune plasticity and innate immune rapid responders that may also determine site specific patterns of inflammation.

The path ahead for understanding Toll-like receptors–driven systemic autoimmunity

Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.

TLR2 and TLR4 in autoimmune diseases: a comprehensive review

Role of DNA/RNA sensors and contribution to autoimmunity

The Role of Toll-Like Receptors in Autoimmune Diseases through Failure of the Self-Recognition Mechanism

Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

From Molecular Mechanisms to Clinical Applications

Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease

How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders

Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus

Application and Prospect of Targeting Innate Immune Sensors in the Treatment of Autoimmune Diseases

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

TLR10: Insights, controversies and potential utility as a therapeutic target

Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update

Regulation of the nucleic acid-sensing Toll-like receptors

Toll-Like Receptors: Role in Dermatological Disease

Pattern recognition by Toll-like receptors

Mechanisms controlling nucleic acid-sensing Toll-like receptors

Decoding Toll-like receptors: Recent insights and perspectives in innate immunity